Skip to main content
. 2023 Jun 21;5(15):3994–4001. doi: 10.1039/d2na00787h

Fig. 1. Schematic illustration of the facile synthesis of NaGdF4@PEG@bevacizumab–Cy5.5 nanoparticles (NPBCNs) and their biomedical application as a contrast agent for MRI and fluorescence imaging for the diagnosis of endometriosis.

Fig. 1